LAURIE VICKERY: Open Payments
NPI 1538814785 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 35 payments from 16 companies in 2025. Trend: 2023 $863 · 2024 $516 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $260 |
| Janssen Biotech, Inc. | 11 | $162 |
| Pharmacosmos Therapeutics Inc. | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Merck Sharp & Dohme LLC | 3 | $50 |
| Incyte Corporation | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $22 |
Products named: REPATHA, DARZALEX, MONOFERRIC, LIBTAYO, KEYTRUDA, ERLEADA, RYBREVANT, Nubeqa.
Industry payments across AL — which companies pay providers there.
